Why Eli Lilly Is Buying Centessa for $7.8 Billion

Bloomberg Intelligence’s Sam Fazeli discusses Eli Lilly’s $7.8 billion acquisition of Centessa, marking the company’s entry into the sleep disorder drug market.

He speaks on “Bloomberg Open Interest.” (Source: Bloomberg)

原文链接: Bloomberg